265 results on '"Falkenburg J. H. F."'
Search Results
2. What Defines a Good Tumour Antigen?
3. Apoptin Induces Apoptosis in Human Transformed and Malignant Cells but not in Normal Cells
4. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
5. Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
6. Donor T-cell responses and disease progression patterns of multiple myeloma
7. A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma
8. Fetal Hematopoiesis During First and Second Trimester of Pregnancy: Relevance for In Utero Stem Cell Transplantation
9. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
10. Umbilical Cord Blood as an Alternative Source of Haematopoietic Stem Cells for Transplantation
11. Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL
12. High Levels of Circulating Hematopoietic Progenitor Cells after Continuous Infusion of High Dose Interleukin-2 in Cancer Patients
13. T helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigens
14. Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells
15. Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia
16. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia
17. Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning
18. Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria
19. Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells
20. Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience
21. Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice
22. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity
23. Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNγ-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion
24. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy
25. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells
26. Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity
27. Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cells
28. High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment
29. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
30. An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia
31. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1 specific CD4+ T-cell responses showing immunogenicity of all HLA-DP alleles: O417
32. Identification of four new HLA class II restricted minor histocompatibility antigens as haematopoietic targets in anti-tumour immunity: O404
33. The absolute number as well as the activation kinetics of regulatory T-cells determines the successful generation of primary anti-tumour and pathogen-specific immune responses from the naïve donor T-cell repertoire: O292
34. Allogeneic stem cell transplantation for multiple myeloma with a T-cell depleted reduced-intensity conditioning regimen using both unrelated and related donors: O160
35. Extramedullary hematopoietic growth factor and cytokine gene expression indicate endocrine regulation of hematopoiesis in patients with acute appendicitis
36. The role of cytokines and hematopoietic growth factors in the autocrine/paracrine regulation of inducible hematopoiesis
37. Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy
38. Relative contribution of naive and memory T cells to alloreactivity in hematopoietic stem cell transplantation
39. Interleukin-10, interleukin-12, and tumor necrosis factor-α differentially influence the proliferation of human CD8+ and CD4+ T-cell clones
40. Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens
41. High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma
42. Clonally expanded T cells in hairy cell leukemia patients are not leukemia specific
43. IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes
44. Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin
45. Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood
46. Biology and treatment of myelodysplastic syndromes — developments in the past decade
47. Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF
48. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
49. HLA-DM mediates permissiveness of T-cell alloreactivity to HLA-DPB1
50. HLA-DR4 AND HLA-DR15 LOWER THE RISK OF THE ACQUISITION OF CHRONIC MYELOID LEUKEMIA (CML)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.